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Assisted reproductive technology (ART) has become increasingly 
globalised, with approximately 80% of the world’s population living 
in countries where ART is practised.1 The growing impact of ART 
on human reproduction has resulted in a call for data on its efficacy 
and safety. Information on treatment safety and outcome is relevant 
to patients, the general public, healthcare planners, funders, and ART 
units.2 Relevant information cannot, however, be extrapolated from 
research trials; rather, a data registry is required. 
Efficacy and safety data are collected at national, regional and 
global level. The World Collaborative Report on ART gave an account 
of approximately 930 000 initiated ART cycles from 54 countries, 
representing an estimated 60 - 70% of global ART activity.3 These 
data were derived from all world regions except sub-Saharan Africa, 
where no country had monitored ART. To close the information 
gap in South Africa, the South African Society of Reproductive 
Medicine and Gynaecological Endoscopy (SASREG) established a 
sub-committee in 2007 to institute voluntary, national, anonymous 
ART data monitoring. We report the results of the first data collection.
ART is defined as ‘all treatments or procedures that include the in 
vitro handling of both human oocytes and sperm, or embryos, for the 
purpose of establishing a pregnancy’.4 This does not include artificial 
insemination. Oocytes are aspirated from ovaries (usually after 
ovarian stimulation), incubated in culture medium and fertilised by 
the addition of spermatozoa – a process termed in vitro fertilisation 
(IVF). If sperm quality is poor, sperm are injected into oocytes by 
intracytoplasmic sperm injection (ICSI). Successful fertilisation via 
IVF or ICSI gives rise to human zygotes which develop into embryos 
then blastocysts; either of these is introduced into the recipient 
through trans-cervical intra-uterine transfer. No law or guideline in 
South Africa currently stipulates how many embryos/blastocysts may 
be transferred. 
Biochemical pregnancy is characterised by raised serum human 
chorionic gonadotrophin (hCG), detected as early as 10 days after 
initial aspiration. Pregnancy may progress to clinical pregnancy 
– either viable intrauterine pregnancy or early pregnancy loss 
(miscarriage and ectopic pregnancy). A percentage of clinical 
pregnancies will result in live births.
Published reports on national, regional and global ART data 
monitoring – including this manuscript – have not undergone ethics 
committee review or approval.3,5-7 The reported data are anonymous 
and were collected on a voluntary basis. The data were pooled and 
de-linked from the source databases; therefore, there is no risk to 
patient confidentiality.
Methods
All known ART units were invited to join the South African Register 
of Assisted Reproductive Techniques (SARA). Consultation on the 
type of data to collect and the data collection means was informed 
by international recommendations and consensus documents.2,4 
International collaboration was developed with the International 
Committee Monitoring ART (ICMART) and the Latin American 
Registry of ART (Registro Latinoamericano de Reproducción 
Asistida) (RLA).
National data collection was initiated in a 2-step approach. In 
the first step, 2009 data were collected using a Microsoft Excel 
spreadsheet: data collected pertained to the number of cycles, embryo 
transfers, clinical pregnancies, age of female partner and egg donor, 
and use of fertilisation techniques (IVF and ICSI). Only fresh embryo 
transfers were included. Procedures and outcomes were defined in 
keeping with the ICMART-WHO glossary.4 ‘Aspiration’ was defined 
as attempted oocyte retrieval irrespective of the outcome. In cycles 
where both IVF and ICSI were used, the technique that gave rise to 
the embryo(s) transferred was captured; ICSI was recorded as the 
default if embryos from both techniques were transferred. Donor 
egg aspirations, embryo transfers and clinical pregnancies were 
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Objective. We present the first report from the South African 
Register of Assisted Reproductive Techniques.  
Methods. All assisted reproductive technology (ART) centres in 
South Africa were invited to join the register. Participant centres 
voluntarily submitted information from 2009 on the number of 
ART cycles, embryo transfers, clinical pregnancies, age of female 
partners or egg donors, and use of fertilisation techniques. Data 
were anonymised, pooled and analysed. 
Results. The 12 participating units conducted a total of 4 512 
oocyte aspirations and 3 872 embryo transfers in 2009, resulting 
in 1 303 clinical pregnancies. The clinical pregnancy rate (CPR) 
per aspiration and per embryo transfer was 28.9% and 33.6%, 
respectively. Fertilisation was achieved by intracytoplasmic sperm 
injection in two-thirds of cycles. In most cycles, 1 - 2 embryos or 
blastocysts were transferred. Female age was inversely related to 
pregnancy rate. 
Conclusion. The register achieved a high rate of participation. 
The reported number of ART cycles covers approximately 6% of 
the estimated ART demand in South Africa. The achieved CPRs 
compare favourably with those reported for other countries.
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all recorded according to the age of the egg donor, and not that of 
the recipient. The number of embryos or blastocysts transferred in 
each cycle was captured, but embryo and blastocyst transfers were 
not reported separately. Only clinical pregnancies were captured – 
defined as ‘any pregnancy with clinical products of conception or 
ultrasonographic evidence of pregnancy’ (this excludes biochemical 
pregnancies). It was anticipated that these data could be provided by 
most of the SARA participating units. In the second step, a software 
programme was developed in collaboration with the RLA for future 
online reporting of more extended data. 
In March 2010 a first call for data was sent to 16 South African 
ART physicians and units. Two units were excluded as they had 
previously declined participation. By the end of 2010, 12 units had 
sent their 2009 summary data to the SASREG secretariat. Data 
were sent electronically with password protection to 2 non-clinical 
members of the secretariat (data managers), whose role was to 
protect data confidentiality, test for mathematical errors, and pool 
data without error. No further attempt was made to validate data 
devoid of mathematical error. The pooled data were analysed by 
the authors.
Results
Data were received from 12 participant ART units. One unit was 
only able to provide data for July - December 2009 for operational 
reasons. Mathematical errors were found in the data from 2 units; 
these were rectified following consultation between the units and the 
data managers.
A total of 4 512 aspirations and 3 872 embryo transfers were 
conducted, resulting in 1 303 clinical pregnancies; the clinical 
pregnancy rate (CPR) per aspiration and per embryo transfer was 
28.9% and 33.6%, respectively. 
Nine units provided information on: (i) fertilisation technique 
(i.e. IVF and ICSI), (ii) age of female partner or egg donor, and 
(iii) number of embryos/blastocysts transferred. These 9 units 
undertook 3 305 aspirations and 2 813 embryo transfers, resulting 
in 974 clinical pregnancies. ICSI accounted for 62.3% of aspirations, 
63.2% of embryo transfers and 59.1% of clinical pregnancies. Table 
1 summarises the data on IVF-related procedures and outcomes 
according to age of female partner or egg donor. Similarly, Table 2/
Fig. 1 shows the number of embryos/blastocysts transferred after IVF. 
Tables 3 and 4 summarise the data pertaining to ICSI-related 
procedures and outcomes, and the number of embryos/blastocysts 
transferred, respectively. Fig. 2 depicts the information contained in 
Table 4.
Discussion 
This is the first report from South Africa and sub-Saharan Africa on 
national anonymous monitoring of ART. Approximately 70% of ART 
units participated, reflecting a willingness to collaborate to obtain 
national ART data. Participation is expected to increase as some non-
participating units have announced their intention to join SARA, 
and others may become convinced of the benefit from national data 
monitoring. 
Optimal population ART coverage has been estimated at 1 500 
cycles per million individuals per year.8,9 South Africa has a large 
unmet ART need: based on a South African population of 44.8 
million people (Census 2001),10 the 4 500 reported aspirations 
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Table 1. In vitro fertilisation (IVF): number of procedures 
and outcomes according to age of female partner or egg 
donor* 
IVF
< 35 
years
35 - 39 
years
>39 
years Total
Aspirations (N) 686 367 191 1 244
Embryo transfers (N) 586 298 150 1 034
Clinical pregnancies (N) 256 104 38 398
CPR†/aspiration (%) 37.1 28.3 19.8 31.9
CPR/embryo transfer (%) 43.7 34.9 25.3 38.5
* Egg donor procedures and outcomes are captured according to age of female partner or 
egg donor, and not recipient age.
† CPR = clinical pregnancy rate. 
Table 2. Number of embryos/blastocysts transferred after 
IVF, according to age of female partner or egg donor
<35 years
N (%)
35 - 39 
years
N (%)
>39 
years
N (%)
Total 
transfers
N (%)
1 embryo/
blastocyst
60 (10.2) 51 (17.1) 37 (24.6) 148 (14.3)
2 embryos/
blastocysts
399 (68) 135 (45.3) 44 (29.3) 578 (55.9)
3 embryos/
blastocysts
97 (16.5) 80 (26.8) 46 (30.6) 223 (21.6)
4 or more 
embryos/
blastocysts
30 (5.1) 32 (10.7) 23 (15.3) 85 (8.2)
Total transfers 586 (100) 298 (100) 150 (100) 1 034
Fig. 1. Distribution of the different number of embryos/blastocysts trans-
ferred following IVF, according to age of female partner or egg donor. The 
3 age categories are shown on the x-axis. The y-axis captures percentage of 
transfers with a given number of embryos/blastocysts per age group; 100% = 
all embryo transfers in the age group.
Table 3.  Intracytoplasmic sperm injection (ICSI): number 
of procedures and outcome, according to age of female 
partner or egg donor
ICSI <35 years
35 - 39 
years
>39 
years Total 
Aspirations (N) 992 702 367 2 061
Embryo transfers (N) 913 595 271 1 779
Clinical pregnancies (N) 328 189 59 576
CPR per aspiration (%) 33 26.9 16 27.9
CPR per embryo 
transfer (%)
35.9 31.8 21.8 32.2
169March 2012, Vol. 102, No. 3  SAMJ
represent approximately 6% of optimal ART coverage. Barriers to 
ART include the cost, which is poorly – if at all – covered by private 
health insurances; access in the public health sector is limited to 
very few institutions, and patients usually have to contribute to the 
costs. Out-of-pocket payment for a standard IVF cycle with standard 
ovarian stimulation ranges from approximately R10 000 (subsidised 
care in the public sector) to R35 000 (private sector care). The impact 
of appropriate funding for ART was illustrated in Germany, where 
a reduction of third-party ART reimbursement in 2004 resulted in 
almost a 50% drop in annual treatment cycles.5 Geographical barriers 
also exist: South Africa’s limited number of ART units are found in 
urban areas. Additional constraints to the extensive uptake of ART 
include a lack of knowledge, religious beliefs, and a lack of trust in a 
costly technique of varying success, which is not always outlined in a 
consistent or transparent manner. 
The CPR per aspiration was 31.9% for IVF and 27.9% for ICSI. 
Evidently, the CPR per embryo transfer was higher (38.5% for 
IVF and 32.2% for ICSI), as some aspirations were unsuccessful, 
and in certain cycles none of the retrieved oocytes developed 
into embryos. These results are reassuring and reflect a sound 
efficacy of ART in South Africa. They are within the mid-range 
of internationally reported data, although any such comparison 
is fraught with difficulty because of inherent differences in the 
collected data. The World Report on ART monitoring, which 
captured data from 2003, documented a variable IVF CPR per 
aspiration of between 11.8% (Guatemala) and 41.7% (Taiwan), 
with most countries situated between 20% and 35%. The global 
CPR per aspiration was 28.6% for IVF and 29.4% for ICSI.3 Similar 
results were reported from the European register: approximately 
450 000 ART cycles conducted in 2006 were recorded (including 
frozen embryo replacement), resulting in a CPR per aspiration of 
29% (IVF) and 29.9% (ICSI).5 Large variations were noted between 
countries, including differences in national coverage of ART, age of 
the women treated, number of embryos/blastocysts transferred, and 
multiple pregnancy rates. 
ICSI, rather than standard IVF, was performed in 62.3% of 
aspirations. Very similar rates have been reported from the USA, 
Europe and Australia in 2006.5 Moreover, regional and international 
registers have observed the growing use of ICSI, attributable to 
changes in professional practice, rather than an overall increase in 
male factor infertility.5,11 It will be interesting to monitor this trend 
in South Africa, with the knowledge that ICSI does not improve the 
outcome of ART for non-male infertility.11
Approximately 50% of women undergoing IVF and ICSI were 
under the age of 35, representing almost two-thirds of all clinical 
pregnancies reported; 15 - 17% were ≥40 years, with approximately 
1/10 pregnancies occurring in this age-group. It is encouraging that 
most patients underwent ART at a young age, when the prognosis for 
pregnancy is best. A CPR per embryo transfer of 25.3% (IVF) and 
21.8% (ICSI) in women >39 years is acceptable, bearing in mind that 
the data for women receiving donor eggs were captured according 
to the donor age. Conversely, this may have led to an inflation of 
numbers in the younger age group. 
Female age was inversely related to number of embryos/blastocysts 
transferred. Most women aged ≥40 years received 3 embryos/
blastocysts, while in the 2 younger age categories, 2 was the 
most common number transferred. In all age groups, single and 
multiple embryo/blastocyst transfers took place. The transfer of more 
embryos/blastocysts, especially in older women, aims to optimise 
the chance of conception with acceptance of the risk of multiple 
pregnancy. Documenting the extent of this risk is an important future 
task for SARA.
Our first report has limitations. Firstly, not all South African ART 
units participated; although our findings represent approximately 
70% of ART activity, they cannot be extrapolated to all ART treatment 
in the country. Secondly, the data submitted were accepted in good 
faith and were only tested for mathematical correctness. Although it 
is unlikely, discrepancies may exist between the reported and actual 
clinical data. Data inflation poses no conceivable benefit to the units; 
confidentiality and anonymity of the individual data were protected, 
and only pooled data were analysed and reported. Futhermore, based 
on our in-depth knowledge of ART in South Africa, we consider the 
results of the pooled data to be plausible.
This report documents CPR – rather than live birth rate (LBR) – as 
a marker of efficacy. LBR (increasingly singleton LBR) is the preferred 
indicator of ART success;12 however, many South African ART units do 
not follow pregnant patients beyond the first ultrasound (performed 
at 6 - 8 weeks of gestation when fetal heart activity and number of 
viable embryos can be detected). This is because the patients usually 
enter private or public obstetric services elsewhere. Similarly, the 
report does not document the rate of multiple pregnancy and birth, 
which is of central interest to ART data-monitoring. A relatively high 
CPR may be achieved through the practice of transferring several 
embryos/blastocysts; however, this risks twin and higher multiple-
order pregnancies. The associated morbidity and mortality for 
fetuses and the mother has been established. Furthermore, multiple 
pregnancies are costly to health services and are a major factor in 
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Table 4. Number of embryos/blastocysts transferred follow-
ing ICSI, according to age of female partner or egg donor
<35 years
N (%)
35 - 39 
years
N (%)
>39 years
N (%)
Total 
transfers
N (%)
1 embryo/
blastocyst
76 (8.3) 81 (13.6) 54 (19.9) 211 (11.9)
2 embryos/
blastocysts
565 (61.8) 295 (49.6) 83 (30.6) 943 (53)
3 embryos/
blastocysts
218 (23.8) 169 (28.4) 97 (35.8) 484 (27.2)
4 or more 
embryos/
blastocysts
54 (5.9) 50 (8.4) 37 (13.6) 141 (7.9)
Total transfers 
N (100%)
913 (100)  595 (10.7) 271 (100) 1 779 
(100)
Fig. 2. Distribution of the different number of embryos/blastocysts trans-
ferred after ICSI, according to age of female partner or egg donor. The 3 
age categories are shown on the x-axis. The y-axis captures percentage of 
transfers with a given number of embryos/blastocysts per age group; 100% = 
all embryo transfers in the age group.
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discussions concerning government and private insurance funding 
of ART. Given the importance of live and multiple births to all 
stakeholders, we intend to report these outcomes from 2012. 
Additional information missing from this report includes the 
indication for treatment, number of egg donations, number and 
outcome of frozen embryo transfers, and ART complications. We 
intend to include this information in a more extended data capture 
commencing in 2012, using software developed with the South 
American Register for ART. Although SARA was designed for South 
Africa, its format is aligned to the South American register, thereby 
facilitating future comparison of data. Countries of South America 
have social, political and economic similarities to South Africa; 
therefore, this region is important as a benchmark against which to 
evaluate South African data. SARA’s adherence to internationally 
defined and standardised recordings of ART will, however, allow 
comparison with any country or region, especially once SARA 
reports to international ART registers.
Conclusion
Despite its limitations, the first report on ART monitoring in South 
Africa contains valuable information for many stakeholders: (i) 
couples requiring ART can gauge their individual chance of success, 
as advised by the treating doctor, against a national average and 
age-specific CPR; (ii) ART units can compare their performance 
with a national benchmark; (iii) healthcare funders and planners 
have insight into the number of ART procedures and outcomes, 
and the extent to which ART demand is met in our country; and 
(iv) the general public is informed that ART is well established, with 
monitored and reported outcomes.
Contributions. The following units participated: Cape Fertility 
Clinic (Drs P le Roux, S Heylen, K Wiswedel, S Nosarka, R Dhansay, 
Ms K Raja); Care Clinic (Dr A Ramdeo, Mr K Naidoo); Drs Aevitas 
Incorporated (Profs/Drs T Kruger, I Siebert, K van der Merwe, 
Dr M Windt de Beer); Durban Fertility Clinic (Drs S Naidu, M 
Bhana, Mr N Moodley); Genesis Reproductive Centre (Drs A de 
Bruin, J Pentz, G Hogewind, Mr J Lourens); Medfem Clinic (Drs J 
van Rensburg, J van Schouwenburg, T Rodrigues, A Esterhuizen); 
Parklane Fertility Centre (Dr H Netshidvhani, Ms S Karadasli); Port 
Elizabeth Infertility Unit (Drs P Dalmeyer, D Botha, Ms M Rijsdijk); 
Pretoria Fertility Clinic (Dr M Trouw, Mrs E Prinsloo); Reproductive 
Medicine Unit, Groote Schuur Hospital (Profs/Drs S Dyer, Z van der 
Spuy, T Matebese, Mrs M Vienings); Sandton Fertility Centre (Drs G 
Mohamed, M Faesen, R Patel, Ms K Raja); and Vitalab Fertility Unit 
(Drs S Volschenk, M Jacobson, L Gobetz, Ms J Meintjies).
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